Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $4.0 million.

  • Ekso Bionics Holdings' Operating Expenses fell 1850.25% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.9 million, marking a year-over-year decrease of 916.29%. This contributed to the annual value of $20.0 million for FY2024, which is 1744.45% down from last year.
  • According to the latest figures from Q3 2025, Ekso Bionics Holdings' Operating Expenses is $4.0 million, which was down 1850.25% from $4.8 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Operating Expenses' 5-year high stood at $7.0 million during Q4 2021, with a 5-year trough of $4.0 million in Q3 2025.
  • For the 5-year period, Ekso Bionics Holdings' Operating Expenses averaged around $5.3 million, with its median value being $5.2 million (2024).
  • Its Operating Expenses has fluctuated over the past 5 years, first surged by 5986.69% in 2021, then plummeted by 2395.23% in 2024.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Operating Expenses stood at $7.0 million in 2021, then fell by 12.24% to $6.1 million in 2022, then decreased by 4.84% to $5.8 million in 2023, then fell by 15.02% to $4.9 million in 2024, then decreased by 20.08% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $4.8 million for Q2 2025, and $5.2 million during Q1 2025.